Accent Group (ASX:AX1) report boost in online sales

25Jun

Accent Group (ASX:AX1) report boost in online sales

 

Footwear retailer Accent Group (ASX:AX1) says online sales strengthened over the months of May and June with financial year 2020 EBITDA 10 per cent above the $108.9 million in financial year 2019.

Over financial 2020 total like-for-like sales climbed 1.6 per cent, with digital sales over April to June up 150 per cent on the prior corresponding period. Digital sales in May totalled $29 million.

All stores were closed on 27 March and Australian stores re-opened for trade by 11 May and New Zealand stores reopened on 22 May.

This was enabled by the Jobkeeper program in Australia and the New Zealand wage subsidy scheme.

Shares in Accent Group (ASX:AX1) are trading 7.7 per cent higher at $1.47.

 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

18Jan

Stocks of the Hour: Gateway Mining, Sabre Resources, Ionic Rare Earths

18 Jan 2024 - A snapshot of the stocks on the move, featuring Gateway Mining (ASX:GML), Sabre Resources (ASX:SBR) and Ionic Rare Earths (ASX:IXR).

Read More
15Apr

Alcidion (ASX:ALC) finalises terms for ExtraMed takeover

15 Apr 2021 - Healthcare informatics developer Alcidion (ASX:ALC) has ironed out terms for the proposed takeover of British health technology specialist ExtraMed.

Read More
15Jan

Resolute Mining (ASX:RSG) divests Ravenswood Gold Mine

15 Jan 2020 - Resolute Mining (ASX:RSG) has sold its Ravenswood Gold Mine in Queensland to a consortium comprising EMR Capital and Golden Energy & Resources for up to $300 million.

Read More
23Jul

Audinate Group (ASX:AD8) completes $28 million placement

23 Jul 2020 - Audinate Group (ASX:AD8) developer of the professional AV-industry leading Dante media networking solutions, has successfully completed a $28 million fully underwritten placement.

Read More
15Dec

Mesoblast (ASX:MSB) report improved outcome in heart failure patients

15 Dec 2020 - Cellular medicine company Mesoblast (ASX:MSB) announced top-line results from the landmark DREAM-HF Phase 3 trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR®) in 537 patients with advanced chronic heart failure.

Read More
07Aug

Stocks of the Hour: Arrow Minerals, LBT Innovations, Castle Minerals

07 Aug 2024 - A snapshot of the stocks on the move, featuring Arrow Minerals (ASX:AMD), LBT Innovations (ASX:LBT) and Castle Minerals (ASX:CDT).

Read More
05Oct

Stocks of the Hour: Vintage Energy, Rumble Resources, QX Resources, Dimerix, BluGlass

05 Oct 2023 - A snapshot of the stocks on the move, featuring Vintage Energy (ASX:VEN), Rumble Resources (ASX:RTR), QX Resources (ASX:QXR), Dimerix (ASX:DXB) and BluGlass (ASX:BLG).

Read More
03Feb

Lynas Corporation (ASX:LYC) awarded Major Project Status

03 Feb 2020 - The Australian Government has awarded rare earth producer, Lynas Corporation (ASX:LYC) Major Project Status to establish its new processing plant in Kalgoorlie, Western Australia.

Read More
24Sep

Superloop to raise $90 million and recapitalise existing senior debt

24 Sep 2019 - Superloop (ASX:SLC) has announced a $90 million equity raising at a price of 82 cents a share.

Read More
08Nov

Virgin Australia (ASX:VAH) has been authorised to cooperate with Virgin Atlantic

08 Nov 2019 - The ACCC has issued a determination authorising Virgin Australia (ASX:VAH) to work more closely with Virgin Atlantic on flights between Australia and the UK and Ireland; via Hong Kong, Los Angeles and any other future connecting points.

Read More